Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

kidney · Mechanism Report

Can reduced kidney function raise circulating trimethylamine N-oxide?

Reduced kidney function can raise circulating trimethylamine N-oxide because the kidney is a major route of its elimination.

PlausibleOctober 16, 20264 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Reduced kidney function can raise circulating trimethylamine N-oxide because renal excretion is a major route of elimination.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that when kidney function declines, trimethylamine N-oxide can accumulate in the circulation. The evidence framing emphasizes impaired renal clearance, including urinary elimination of TMAO and rapid removal during hemodiafiltration, as the mechanism linking reduced filtration to higher levels.

Verified conclusion

Reduced kidney function is a well-supported cause of higher circulating trimethylamine N-oxide (TMAO), because the kidney normally provides substantial elimination of TMAO, predominantly as unchanged compound in urine.

Clinical and clearance evidence

  • A systematic review and meta-analysis found a moderate inverse association between glomerular filtration rate (GFR) and circulating TMAO (Fisher’s z = −0.45, 95% CI −0.58 to −0.32): lower GFR generally coincided with higher TMAO.
  • In healthy individuals, reported urinary TMAO clearance was 219 ± 78 mL/min, exceeding typical creatinine clearance. This pattern indicates that elimination is not limited to glomerular filtration; tubular secretion appears to contribute materially.
  • In pediatric chronic kidney disease, plasma TMAO rose with worsening disease severity while urinary TMAO was lower, consistent with impaired renal elimination.

Mechanistic and dialysis evidence

  • TMAO is largely excreted unchanged in urine. Thus, loss of filtration capacity—and potentially reduced tubular secretory capacity—can promote systemic accumulation.
  • In a small hemodialysis study, four hours of hemodiafiltration reduced mean TMAO from 90.8 to 14.7 μmol/L, an 84.9% fractional reduction. This rapid removal provides direct evidence that clearance of TMAO can substantially determine its circulating concentration.

Clinical interpretation

  • Kidney impairment is an important determinant of a high TMAO result, but it is not necessarily the only determinant. Dietary precursor exposure, gut microbial trimethylamine generation, hepatic FMO3-mediated conversion to TMAO, medications, and cardiometabolic illness can also affect concentrations.
  • Therefore, elevated TMAO in a 52-year-old man with reduced kidney function should be interpreted partly as a consequence of reduced elimination, rather than assumed to reflect diet or microbiome activity alone.

Bottom line

  • Reduced kidney function can raise circulating TMAO because renal excretion is a major elimination route. The conclusion is strongly supported by urinary-clearance data, the inverse GFR–TMAO relationship, and marked TMAO removal during hemodiafiltration.

References

  1. Gut Microbiota-Derived Trimethylamine N-Oxide and Kidney Function: A Systematic Review and Meta-Analysis — pmc.ncbi.nlm.nih.gov ↗
  2. Trimethylamine N -Oxide: The Good, the Bad and the Unknown — pmc.ncbi.nlm.nih.gov ↗
  3. 1801 Gut dysbiosis contributes to TMAO accumulation in CKD — academic.oup.com ↗
  4. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible16 sourcesCan gadolinium be retained after MRI contrast, and does a urine result alone tell the full story?→Plausible10 sourcesDo an undetectable UACR and optimal SDMA provide reassuring kidney context without measuring TMAO clearance?→